BVF »

Foghorn Therapeutics shares owned by BVF

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by BVF from 13F filings

Historical chart of BVF investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by BVF

Quarter filed Position value Share count Share price at filing
2024-06-30 $31M 5.3M 5.75

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Ionis Pharmaceuticals (IONS)
Mirum Pharmaceuticals (MIRM)
Gh Research Ordinary Shares (GHRS)
Protagonist Therapeutics (PTGX)
Cullinan Oncology (CGEM)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Sponsored Ads (GPCR)
Xoma Corp Del Com New (XOMA)
Kura Oncology (KURA)
4d Molecular Therapeutics In (FDMT)
Axsome Therapeutics (AXSM)
Cg Oncology (CGON)

View all positions for BVF

Top funds holding Foghorn Therapeutics

Flagship Ventures Management
BVF
Deerfield Management Company
Raymond James & Associates
Euclidean Capital
BlackRock
Vanguard Group
Artal Group
Driehaus Capital Management
Perceptive Advisors
Geode Capital Management
Alphabet
State Street Corporation
Point72 Asset Management
Birchview Capital

View all funds holding Foghorn Therapeutics